StockNews.com Initiates Coverage on Avinger (NASDAQ:AVGR)

Equities researchers at StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR) in a research report issued to clients and investors on Saturday. The firm set a “hold” rating on the medical device company’s stock.

Avinger Price Performance

AVGR stock opened at $0.47 on Friday. The business’s fifty day moving average is $0.64 and its 200-day moving average is $0.84. The company has a market cap of $1.57 million, a P/E ratio of -0.04 and a beta of 1.09. Avinger has a twelve month low of $0.36 and a twelve month high of $5.45.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.